| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.2M | +54.7% |
| Cost of Revenue | $10.8M | +78.3% |
| Gross Profit | $5.4M | +22.1% |
| R&D Expense | $1.5M | +50.1% |
| SG&A Expense | $2.1M | +21.3% |
| Operating Income | $1.8M | +6.4% |
| Pre-tax Income | $1.7M | -1.3% |
| Income Tax | -$307K | -454.4% |
| Net Income | $2.2M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.7M | -18.0% |
| Short-term Investments | $716K | -7.1% |
| Accounts Receivable | $5.3M | +76.3% |
| Current Assets | $12.4M | +7.7% |
| Total Assets | $14.4M | +9.5% |
| Current Liabilities | $3.5M | -9.0% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $136K | -94.8% |
| Capital Expenditures | $67K | +216.8% |
| Investing Cash Flow | -$347K | -4862.8% |
| Financing Cash Flow | -$81K | -140.4% |
| Free Cash Flow | $70K | -97.3% |
| +33.5% |
| EPS (Basic) | $0.06 | +20.0% |
| EPS (Diluted) | $0.06 | +20.0% |
| Total Liabilities |
| $3.5M |
| -9.0% |
| Stockholders' Equity | $10.0M | +13.0% |